From: Mechanisms underlying linear ubiquitination and implications in tumorigenesis and drug discovery
Gene | Ubiquitination site | Linear ubiquitination function | Ref |
---|---|---|---|
AGO2 | K820 | Interfering miRNA-targeted mRNA recruiting to AGO2 | [69] |
ALK1 | K210, K229, K440, K491 | Inhibiting ALK1 enzyme activity and Smad1/5 activation | [70] |
BCL10 | K17, K31, K63 | Recruiting NEMO to activate IKK and NF-κB | [71] |
CASP8 | Not determined (n.d) | Probably required for TRAIL-induced NF-κB activation | [41] |
cFLIP | K351, K353 | Protecting cells from TNFα-induced apoptosis | [72] |
IRAK1/2/4 | n.d | Recruiting NEMO to activate IKK and NF-κB | |
LKB1 | n.d | Activating AMPK pathway to inhibit NLRP3 inflammasome response | [75] |
MyD88 | n.d | Recruiting NEMO to activate IKK and NF-κB | |
NEMO | K285, K309 | Required for TNFα- and IL1β-induced NF-κB activation | |
PINK1 | n.d | Stabilizing PINK1 protein and counteracting OTULIN activity | [68] |
PTEN | K144, K197 | Inhibiting PTEN phosphatase activity | [77] |
RIPK1 | n.d | Required for TNFα-induced NF-κB activation | |
RIPK2 | n.d | Augmenting NOD2-dependent proinflammatory signaling | [30] |
STAT1 | K511, K652 | Inhibiting STAT1 binding to the type I IFN receptor IFNAR2 | [78] |
STAT3 | K153, K161, K163, K199 | Recruiting the phosphatase TC-PTP to STAT3 to reduce STAT3 activity | [79] |
TNFR1 | n.d | Probably required for NF-κB activation | [30] |